|Cardiology Now is a series of short podcast discussions between Dr Payal Kohli of the University of California San Francisco and experts in cardiovascular medicine. Dr Kohli and guests provide concise perspective for primary care practice on what’s new in the prevention, assessment, and management of cardiovascular disease. More here… |
Residual Cardiovascular Risk: New Research on Particle Behavior
February 11, 2013
Two studies have demonstrated novel research directions for LDL-C and LDL-P. The first revealed that when LDL-C and LDL-P are concordant (that is either both high, normal, or low), either can serve as a good measure of CV risk. However, when they are discordant, cardiovascular events increase.
Lipid-lowering Injectable Antibodies: The Next Big Thing?
November 28, 2012
Anti-PCSK-9 monoclonal antibodies were shown to reduce LDL-C levels up to 85% in the hardest to treat patients in a group of clinical trials reported at the AHA 2012 Scientific Sessions this month. Principal investigator Dr Robert Giuliagno highlights his study and other late breaking clinical trials, here.
May 9, 2011
A 59-year-old woman had aphasia and right-sided weakness after a routine total knee replacement. CT and MRI scans revealed a large left middle cerebral artery infarct. A CT angiogram showed no significant disease of the cerebrovascular arteries. Test results for the lupus anticoagulant were positive. A venous study of the legs showed no deep venous thrombosis. She was treated with warfarin and aspirin and discharged. After speech and physical therapy, she had mild residual aphasia.
Regular Exercise in Middle Age Can Build Heart Muscle
April 8, 2011
Exercising at least 4 times a week can increase left ventricular mass and preserve elasticity, thereby reducing the risk of diastolic heart failure. Researchers from Texas presented their study results at the American College of Cardiology’s 60th Annual Scientific Session.
Pulse Pressure May Be Clue to White Coat Hypertension
April 8, 2011
Measurement of pulse pressure may help identify patients with "white coat" hypertension, according to data presented by Korean researchers at the American College of Cardiology’s 60th Annual Scientific Session.
Shorter Antiplatelet Regimen Sufficient After Stenting
April 8, 2011
What is the optimal duration for antiplatelet therapy after placement of drug-eluting stents? Initial results of the EXCELLENT study show that 6 months of antiplatelet therapy is as effective as the 12-month regimen recommended by current guidelines.
CABG Bests Medical Therapy in Ischemic Heart Failure
April 5, 2011
Compared with medical therapy alone, coronary artery bypass grafting (CABG) significantly reduced cardiovascular deaths and the composite end point of all-cause deaths and cardiovascular-related hospitalizations, reported investigators from the Surgical Treatment of Ischemic Heart Failure (STICH) trial. However, the effect of the two management strategies on overall survival in patients with ischemic heart failure was similar.
Showing 21 - 30 of 47 results.
Scimitar Syndrome in Turner Syndrome
May 16, 2011
A 39 year-old female with Turner Syndrome completely asymptomatic in the previous years, presented to our department with recent onset of dizziness and fatigue.
September 7, 2011
An 18-year-old woman with no known medical history presented to the ED complaining of fever, chills, and rigors of a week’s duration. The patient appeared very ill with hypotension, tachycardia, tachypnea, and fever.
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access Judy Capko,
May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
CARDIO VASCULAR DISEASES MEDICATIONS
SearchMedica Search Result
Find peer-reviewed literature and websites for practicing medical professionals